Versant Vantage Ii Gp-Gp, Llc
10% Owner at LENZ Therapeutics, Inc. (LENZ)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $10.4M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 2SEC | LENZLENZ Therapeutics, Inc. | Sell | 49,7011,133,842 held (−4%) | $45.35 | $2.3M | -92.0% |
| Oct 2SEC | LENZLENZ Therapeutics, Inc. | Sell | 34,405821,752 held (−4%) | $45.35 | $1.6M | -92.0% |
| Oct 2SEC | LENZLENZ Therapeutics, Inc. | Sell | 83,0661,050,776 held (−7%) | $46.41 | $3.9M | -92.1% |
| Oct 2SEC | LENZLENZ Therapeutics, Inc. | Sell | 57,502764,250 held (−7%) | $46.41 | $2.7M | -92.1% |
| Oct 2SEC | LENZLENZ Therapeutics, Inc. | Sell | 1771,050,599 held (−0%) | $47.01 | $8K | -92.2% |
| Oct 2SEC | LENZLENZ Therapeutics, Inc. | Sell | 123764,127 held (−0%) | $47.01 | $6K | -92.2% |